The present invention is a compound and pharmaceutical composition comprising a compound of formula (I):
wherein R1 is a 4-(lower) alkyl-imidazol-1-yl or a 4,5-di(lower) alkyl-imidazol-1-yl group, R2 is a hydrogen atom or a lower alkyl group, and R3 is a fluorenyl group. The compound of formula (I) includes pharmaceutically acceptable salts: The compound of formula (I) and salts thereof have 5-HT antagonism activity.
SHKURKO O. P.; KUZNTSEOV S. A.; DENISOV A. YU.; MAMAEV V. P., XIMIYA GETEROTSIKL. SOED.,(1986) N 7, 951-958
作者:SHKURKO O. P.、 KUZNTSEOV S. A.、 DENISOV A. YU.、 MAMAEV V. P.
DOI:——
日期:——
US6770667B1
申请人:——
公开号:US6770667B1
公开(公告)日:2004-08-03
Quantitative determination of the electronic effects of 3- and 4-pyridazinyl groups from NMR spectral data for isomeric aminophenyl- and phenylpyridazines
作者:O. P. Shkurko、S. A. Kuznetsov、A. Yu. Denisov、V. P. Mamaev